Secondary myelodysplastic syndrome in a patient with Philadelphia-positive acute lymphoblastic leukemia after achieving a major molecular response with hyperCVAD plus imatinib mesylate

被引：0

作者：

Vega-Ruiz, Arturo ^{[1
]}

O'Brien, Susan ^{[1
]}

Cortes, Jorge ^{[1
]}

Kebriaei, Partow ^{[2
]}

Thomas, Deborah ^{[1
]}

Kantarjian, Hagop ^{[1
]}

Ravandi, Farhad ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA

来源：

LEUKEMIA RESEARCH | 2008年 / 32卷 / 09期

关键词：

Philadelphia-positive acute lymphoblastic leukemia; imatinib mesylate; myelodysplastic syndrome;

D O I：

10.1016/j.leukres.2008.02.001

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The addition of imatinib to high-intensity chemotherapy has improved the outcome of patients with Philadelphia chromosome (Ph)-positive acute lymphoblastic leukemia (ALL). However, the possible long-term side effects of this combination are not yet known. Development of new clonal abnormalities in complete cytogenetic remission after treatment with imatinib has been reported in patients with chronic myeloid leukemia but not in patients with Ph-positive ALL. Here, we present a patient with Ph-positive ALL who received hyperCVAD plus imatinib and achieved hematologic, cytogenetic, and major molecular responses. The patient then developed myelodysplastic syndrome and solitary central nervous system relapse of ALL. (C) 2008 Elsevier Ltd. All rights reserved.

引用

页码：1468 / 1471

页数：4

共 26 条

[1]

ABREZZESE E, 2007, CANCER, V109, P2466

[2] Therapy-related adult acute lymphoblastic leukemia with t(4;11)(q21; q23):: MLL rearrangement, p53 mutation and multilineage involvement [J].

Bigoni, R ;

Cuneo, A ;

Roberti, MG ;

Moretti, S ;

De Angeli, C ;

Dabusti, M ;

Campioni, D ;

del Senno, L ;

Biondi, A ;

Chaplin, A ;

Young, BD ;

Castoldi, G .

LEUKEMIA, 1999, 13 (05) :704-707

[3] Isolated central nervous system relapse in lymphoid blast crisis chronic myeloid leukemia and acute lymphoblastic leukemia in patients on imatinib therapy [J].

Bujassoum, S ;

Rifkind, J ;

Lipton, JH .

LEUKEMIA & LYMPHOMA, 2004, 45 (02) :401-403

[4] Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority [J].

Bumm, T ;

Müller, C ;

Al-Ali, HK ;

Krohn, K ;

Shepherd, P ;

Schmidt, E ;

Leiblein, S ;

Franke, C ;

Hennig, E ;

Friedrich, T ;

Krahl, R ;

Niederwieser, D ;

Deininger, MWN .

BLOOD, 2003, 101 (05) :1941-1949

[5] Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones [J].

Chee, YL ;

Vickers, MA ;

Stevenson, D ;

Holyoake, TL ;

Culligan, J .

LEUKEMIA, 2003, 17 (03) :634-635

[6] The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in Philadelphia chromosome-negative cells [J].

Deininger, Michael W. N. ;

Cortes, Jorge ;

Paquette, Ron ;

Park, Byung ;

Hochhaus, Andreas ;

Baccarani, Michele ;

Stone, Richard ;

Fischer, Thomas ;

Kantarjian, Hagop ;

Niederwieser, Dietger ;

Gambacorti-Passerini, Carlo ;

So, Charlene ;

Gathmann, Insa ;

Goldman, John M. ;

Smith, Douglas ;

Druker, Brian J. ;

Guilhot, Francois .

CANCER, 2007, 110 (07) :1509-1519

[7]

Espinet B, 2005, HAEMATOLOGICA, V90, P556

[8] Acute lymphoblastic leukemia with 4;11 translocation analyzed by a multi-modal strategy of conventional cytogenetics, FISH, morphology, flow cytometry and molecular genetics, and review of the literature [J].

Hayne, Cynthia C. ;

Winer, Eric ;

Williams, Tara ;

Chaves, Fernando ;

Khorsand, Jila ;

Mark, Hon Fong L. .

EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2006, 81 (01) :62-71

[9] 11q23 Abnormalities in patients with acute myelogenous leukemia and myelodysplastic syndrome as detected by molecular and cytogenetic analyses [J].

Ibrahim, S ;

Estey, EH ;

Pierce, S ;

Glassman, A ;

Keating, M ;

O'Brien, S ;

Kantarjian, HM ;

Albitar, M .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (05) :793-797

[10] Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia [J].

Kovitz, Craig ;

Kantarjian, Hagop ;

Garcia-Manero, Guillermo ;

Abruzzo, Lynne V. ;

Cortes, Jorge .

BLOOD, 2006, 108 (08) :2811-2813

← 1 2 3 →